<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Age-dependent changes in insulin action and body fat distribution are risk factors for the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>To examine whether the accumulation of visceral fat (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) could play a direct role in the pathophysiology of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we monitored insulin action, <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance, and the expression of adipo-derived <z:chebi fb="7" ids="16670">peptides</z:chebi> after surgical removal of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in aging (20-month-old) F344/Brown Norway (FBN) and in <z:chebi fb="3" ids="16646">Zucker</z:chebi> Diabetic Fatty (ZDF) rats </plain></SENT>
<SENT sid="2" pm="."><plain>As expected, peripheral and hepatic insulin action were markedly impaired in aging FBN rats, and extraction of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> (accounting for approximately 18% of their total body fat) was sufficient to restore peripheral and hepatic insulin action to the levels of young rats </plain></SENT>
<SENT sid="3" pm="."><plain>When examined at the mechanistic level, removal of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in ZDF rats prevented the progressive decrease in insulin action and delayed the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp>, but <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> extraction did not alter plasma free fatty acid levels </plain></SENT>
<SENT sid="4" pm="."><plain>However, the expression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha and leptin in subcutaneous (SC) adipose tissue were markedly decreased after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> removal (by approximately three- and twofold, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, extracted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> retained approximately 15-fold higher resistin <z:chebi fb="2" ids="33699">mRNA</z:chebi> compared with SC fat </plain></SENT>
<SENT sid="6" pm="."><plain>Our data suggest that <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and the development of <z:mp ids='MP_0002055'>diabetes</z:mp> can be significantly reduced in aging rats by preventing the age-dependent accumulation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>This study documents a cause-and-effect relationship between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> and major components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
</text></document>